PointofLaw.com
 Subscribe Subscribe   Find us on Twitter Follow POL on Twitter  
   
 
   

 

 

Drug pricing suits: "the dread Alabama home field advantage"



It came through for Jere Beasley again, per Alison Frankel at American Lawyer: "A state court jury in Tuscaloosa hit the Novartis subsidiary Sandoz with $28.4 million in compensatory and $50 million in punitives." Representing the state of Alabama in the action, Beasley is getting a 14 percent contingency -- very much as if a prosecutor were allowed to pocket a share of fines. Sandoz, which in this case was sued in its generic-drug capacity, is the fourth pharmaceutical defendant to be knocked over in the Alabama campaign, which Beasley is also rolling out elsewhere, getting himself hired by a half-dozen other states to sue over drug pricing sins.

Related Entries:

 

 


Isaac Gorodetski
Project Manager,
Center for Legal Policy at the
Manhattan Institute
igorodetski@manhattan-institute.org

Katherine Lazarski
Press Officer,
Manhattan Institute
klazarski@manhattan-institute.org

 

Published by the Manhattan Institute

The Manhattan Insitute's Center for Legal Policy.